Mediwound Stock Today

MDWD Stock  USD 18.54  0.31  1.70%   

Performance

Modest

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
Mediwound is trading at 18.54 as of the 16th of March 2025, a 1.70 percent increase since the beginning of the trading day. The stock's lowest day price was 18.18. Mediwound has only a 8 % chance of going through financial distress over the next few years but had a somewhat modest performance during the last 90 days. The performance scores are derived for the period starting the 16th of December 2024 and ending today, the 16th of March 2025. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
20th of March 2014
Category
Healthcare
Classification
Health Care
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel. Mediwound operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 10.79 M outstanding shares of which 808.13 K shares are now shorted by private and institutional investors with about 14.0 trading days to cover. More on Mediwound

Moving against Mediwound Stock

  0.46PEPG PepGenPairCorr
  0.44KRYS Krystal BiotechPairCorr
  0.44LUNG Pulmonx CorpPairCorr

Mediwound Stock Highlights

ESG Sustainability
Environmental
Governance
Social
Thematic IdeaPharmaceutical Products (View all Themes)
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, NASDAQ Composite Total, Pharmaceutical Products, Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.30.25
Fairly Up
Slightly volatile
Total Current Liabilities7.6 M12.5 M
Way Down
Slightly volatile
Non Current Liabilities Total17 M21.6 M
Significantly Down
Slightly volatile
Total Assets44.6 M76.4 M
Way Down
Slightly volatile
Total Current Assets38 M57.1 M
Way Down
Slightly volatile
Debt Levels
Mediwound can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Mediwound's financial leverage. It provides some insight into what part of Mediwound's total assets is financed by creditors.
Liquidity
Mediwound currently holds 6.35 M in liabilities with Debt to Equity (D/E) ratio of 0.64, which is about average as compared to similar companies. Mediwound has a current ratio of 1.58, which is within standard range for the sector. Note, when we think about Mediwound's use of debt, we should always consider it together with its cash and equity.

Stock Based Compensation

1.88 Million
Mediwound (MDWD) is traded on NASDAQ Exchange in USA. It is located in 42 Hayarkon Street, Yavne, Israel, 8122745 and employs 100 people. Mediwound is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 200.05 M. Mediwound conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 10.79 M outstanding shares of which 808.13 K shares are now shorted by private and institutional investors with about 14.0 trading days to cover. Mediwound currently holds about 10.41 M in cash with (10.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31.
Check Mediwound Probability Of Bankruptcy
Ownership Allocation
The market capitalization of Mediwound is $200.05 Million. 30% of Mediwound outstanding shares are owned by institutional investors. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Mediwound Ownership Details

Mediwound Stock Institutional Holders

InstituionRecorded OnShares
Wells Fargo & Co2024-12-31
89.4 K
State Street Corp2024-12-31
67.8 K
Ubs Group Ag2024-12-31
66.8 K
Dafna Capital Management Llc2024-12-31
64.5 K
J. Goldman & Co Lp2024-12-31
59 K
Vanguard Group Inc2024-12-31
57.8 K
Legato Capital Management Llc2024-12-31
43.8 K
Prescott Group Capital Management Llc2024-12-31
37.8 K
Morgan Stanley - Brokerage Accounts2024-12-31
35.9 K
Investors Finance Co Plc2024-12-31
872.1 K
Yelin Lapidot Holdings Management Ltd2024-12-31
851.4 K
View Mediwound Diagnostics

Mediwound Historical Income Statement

At present, Mediwound's Income Tax Expense is projected to increase significantly based on the last few years of reporting. The current year's Cost Of Revenue is expected to grow to about 18.2 M, whereas Interest Expense is forecasted to decline to about 466.5 K. View More Fundamentals

Mediwound Stock Against Markets

Mediwound Corporate Management

Yaron AdvGeneral VPProfile
CPA CPAEx DirectorProfile
Ofer BScChief OfficerProfile
Hani LuxenburgChief OfficerProfile
CWS DPMChief OfficerProfile
When determining whether Mediwound is a strong investment it is important to analyze Mediwound's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mediwound's future performance. For an informed investment choice regarding Mediwound Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mediwound. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.
For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mediwound. If investors know Mediwound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mediwound listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.91)
Revenue Per Share
2.062
Quarterly Revenue Growth
(0.09)
Return On Assets
(0.15)
Return On Equity
(0.83)
The market value of Mediwound is measured differently than its book value, which is the value of Mediwound that is recorded on the company's balance sheet. Investors also form their own opinion of Mediwound's value that differs from its market value or its book value, called intrinsic value, which is Mediwound's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mediwound's market value can be influenced by many factors that don't directly affect Mediwound's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mediwound's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mediwound is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mediwound's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.